general
- Generic Name : Dabigatran
- Pronunciation : da-bye-GAT-ran
- ICD Code : Y44.2
- Therapeutic Classification : Anticoagulants / Antithrombotics
- International Brand Name : Pradaxa
prescription
- Prescribed to prevent strokes or severe blood clots in high-risk patients, this medication functions as an anticoagulant (blood thinner). Additionally, it is employed in COVID-19 patients to mitigate the formation of blood clots.
risk factors
- An allergic reaction to Dabigatran or any of its components
- Individuals experiencing active pathological bleeding, such as bleeding from veins, peptic ulcers, or recent surgical sites.
side effects
- Frequently encountered side effects include bleeding in vital areas or organs, indigestion, nausea, upper abdominal pain, gastrointestinal bleeding, and diarrhea.
- Hypersensitivity reactions may manifest as hives, rash, and itching.
dosage
- In individuals with a creatinine clearance (CrCl) exceeding 30 mL/min, the suggested dosage is 150 mg to be taken orally twice daily.
- For patients with a CrCl ranging from 15 to 30 mL/min, the recommended dose is 75 mg twice daily.
how to take
- It is available in capsule form for oral administration, and can be taken with or without food.
warning
- Exercise caution in patients with a history of stomach bleeding, kidney disease, those taking other medications, individuals with allergies, the elderly, children, pregnant, and breastfeeding women.
- Avoid sudden discontinuation, as it may elevate the risk of stroke.
- Patients may experience an elevated risk of bleeding; if such symptoms occur, consult with your doctor.
storage
Keep it in a sealed container at room temperature (25°C) and safeguard it from moisture.